Skip to main content
Past Event

Fostering competition in the pharmaceutical distribution chain

A USC-Brookings Schaeffer Initiative for Innovation in Health Policy event

Past Event

Opening remarks and paper presentation

Opening remarks and paper presentation
Play Video
Now Playing

Opening remarks and paper presentation

Panel discussion: Fostering competition in the brand drug distribution chain
Play Video
Now Playing

Panel discussion: Fostering competition in the brand drug distribution chain

Paper presentation: Would price transparency for generic drugs lower costs for payers and patients?
Play Video
Now Playing

Paper presentation: Would price transparency for generic drugs lower costs for payers and patients?

Panel discussion: Fostering competition in the generic drug distribution chain
Play Video
Now Playing

Panel discussion: Fostering competition in the generic drug distribution chain

Although a great deal of attention concerning prescription drug prices centers on the prices charged by pharmaceutical manufacturers themselves, markups in the distribution chain—pharmacy benefit managers, wholesalers, and pharmacies—are often substantial. Despite the large role that these actors play, little is known about the discounts they negotiate or markups they charge and how those relate to what patients ultimately pay.

On Wednesday, June 14, the USC-Brookings Schaeffer Initiative for Innovation in Health Policy hosted a forum to explore the many segments of the drug distribution chain and examined proposals to reduce price markups through increased competition.

The event featured a presentation of two new papers: one estimating profitability in the distribution chains of both branded and generic drugs and another proposing a transparency scheme to foster competition in the distribution of generic pharmaceuticals. Stakeholder panels followed the presentations of these two papers, to discuss approaches to increase competition in brand and generic drug distribution.

Agenda

Opening Remarks

Dana Goldman

Leonard D. Schaeffer Director's Chair - USC Schaeffer Center for Health Policy & Economics

Distinguished Professor of Public Policy, Pharmacy, & Economics - USC School of Pharmacy and Price School of Public Policy

Nonresident Senior Fellow - Economic Studies, Center for Health Policy

Paper presentation

The flow of funds in the pharmaceutical supply chain

Neeraj Sood

Director of Research - Schaeffer Center for Health Policy & Economics, USC

Vice Dean for Research and Professor - USC Price School of Public Policy

Panel discussion

Fostering competition in the brand drug distribution chain

Ed Adamcik

Chief Pharma Trade Relations Officer - Express Scripts

Jennifer Bryant

Senior Vice President, Policy and Research - Pharmaceutical Research and Manufacturers of America (PhRMA)

Matthew Eyles

Executive Vice President, Policy and Regulatory Affairs - AHIP

Paper presentation

Would Price Transparency for Generic Drugs Lower Costs for Payers and Patients?

Panel discussion

Fostering competition in the generic drug distribution chain

Moderator

Darius Lakdawalla

Quintiles Chair in Pharmaceutical Development and Regulatory Innovation; - USC Schaeffer Center for Health Policy & Economics

Professor - USC School of Pharmacy and Price School of Public Policy

Matthew Eyles

Executive Vice President, Policy and Regulatory Affairs - AHIP

Tom Moriarty

Executive VP, Chief Policy & External Affairs Officer and General Counsel - CVS Health

Christine Simmon

Senior Vice President, Policy & Strategic Alliances - Association for Accessible Medicines

Executive Director - Biosimilars Council

More Information

More

Get a weekly events calendar from Brookings